Cargando…

Tuftsin-phosphorylcholine treatment of autoimmune diseases – a benefit and a message from helminths?

Detalles Bibliográficos
Autores principales:	Maślińska, Maria, de Luca, Fabrizio, Sharif, Kassem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2017
Materias:	Editorial Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825963/ https://www.ncbi.nlm.nih.gov/pubmed/29491533 http://dx.doi.org/10.5114/reum.2017.72622

Ejemplares similares

Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis
por: Blank, Miri, et al.
Publicado: (2018)

Immunomodulation of Murine Chronic DSS-Induced Colitis by Tuftsin–Phosphorylcholine
por: Ben-Ami Shor, Dana, et al.
Publicado: (2019)

Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice
por: Ben-Amram, Hila, et al.
Publicado: (2017)

Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis
por: Bao, Zheng, et al.
Publicado: (2019)

Tuftsin Promotes an Anti-Inflammatory Switch and Attenuates Symptoms in Experimental Autoimmune Encephalomyelitis
por: Wu, Muzhou, et al.
Publicado: (2012)

Promotion of microglial phagocytosis by tuftsin stimulates remyelination inexperimental autoimmune en- cephalomyelitis
por: Bao, Zheng, et al.
Publicado: (2020)

Targeting Phosphorylcholine in Established Atherosclerosis?
por: Tsiantoulas, Dimitrios
Publicado: (2020)

Anti-tumour effect of the physiological tetrapeptide, tuftsin.
por: Nishioka, K.
Publicado: (1979)

Treatment Effect of Tuftsin and Antigen Peptide Combined with Immune Cells on Colorectal Cancer
por: Zou, Boyuan, et al.
Publicado: (2019)

Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis
por: Bhasin, Madhuri, et al.
Publicado: (2007)

COVID-19 – rheumatic diseases and rheumatologists
por: Maślińska, Maria
Publicado: (2021)

Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
por: Thompson, Kaitlyn K., et al.
Publicado: (2018)

Overcharging Effect in Electrospray Ionization Mass Spectra of Daunomycin-Tuftsin Bioconjugates
por: Pethő, Lilla, et al.
Publicado: (2019)

Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection
por: Huang, Jiahao, et al.
Publicado: (2022)

Therapeutic applicability of helminths in autoimmune diseases – literature overview
por: Zwiernik, Jacek, et al.
Publicado: (2019)

Helminth Immunomodulation in Autoimmune Disease
por: Smallwood, Taylor B., et al.
Publicado: (2017)

Dysbiosis, gut–blood barrier rupture and autoimmune response in rheumatoid arthritis and schizophrenia
por: Maślińska, Maria, et al.
Publicado: (2021)

Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice
por: Gao, Yu-Lei, et al.
Publicado: (2015)

Multimodal imaging and photothermal synergistic immunotherapy of retinoblastoma with tuftsin-loaded carbonized MOF nanoparticles
por: Zou, Hongmi, et al.
Publicado: (2022)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

CLONAL NATURE OF THE IMMUNE RESPONSE TO PHOSPHORYLCHOLINE : I. SPECIFICITY, CLASS, AND IDIOTYPE OF PHOSPHORYLCHOLINE-BINDING RECEPTORS ON LYMPHOID CELLS
por: Claflin, J. Latham, et al.
Publicado: (1974)

Inhibition of HeLa cell growth by doxorubicin-loaded and tuftsin-conjugated arginate-PEG microparticles
por: Hu, Tianmu, et al.
Publicado: (2017)

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
por: Silajdžić, Edina, et al.
Publicado: (2015)

Tuftsin prevents the negative immunoregulation of neuropilin-1(high)CD4(+)CD25(+)Regulatory T cells and improves survival rate in septic mice
por: Gao, Yu-Lei, et al.
Publicado: (2016)

Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)

Effects of copolymer component on the properties of phosphorylcholine micelles
por: Wu, Zhengzhong, et al.
Publicado: (2017)

Interpolymer Complexes of Poly(methacryloyloxyethyl phosphorylcholine) and Polyacids
por: Nekrasova, Tatiana, et al.
Publicado: (2022)

Phosphorylcholine Phosphatase: A Peculiar Enzyme of Pseudomonas aeruginosa
por: Domenech, Carlos Eduardo, et al.
Publicado: (2011)

Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice
por: Murugesan, Kalaimathi, et al.
Publicado: (2020)

Tuftsin-tailored fusion protein inhibits the growth of circulating gastric tumor cells associated with macrophage phagocytosis
por: Yuan, Dandan, et al.
Publicado: (2023)

Analysis of Bacterial Phosphorylcholine-Related Genes Reveals an Association between Type-Specific Biosynthesis Pathways and Biomolecules Targeted for Phosphorylcholine Modification
por: Zhang, Yuan, et al.
Publicado: (2023)

Helminths as an alternative therapy for intestinal diseases
por: Sipahi, Aytan Miranda, et al.
Publicado: (2017)

The Role of IgG4 in Autoimmunity and Rheumatic Diseases
por: Maslinska, Maria, et al.
Publicado: (2022)

The Third International Congress on Controversies in Rheumatology & Autoimmunity (CORA): Sorrento, 12–14 March 2015
por: Maślińska, Maria
Publicado: (2015)

Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases
por: de Vries, M. R., et al.
Publicado: (2021)

The place of omega-3 and omega-6 acids in supplementary treatment of inflammatory joint diseases
por: Kwiatkowska, Brygida, et al.
Publicado: (2020)

A Multiscale Study of Phosphorylcholine Driven Cellular Phenotypic Targeting
por: Acosta-Gutiérrez, Silvia, et al.
Publicado: (2022)

Phosphorylcholine Allows for Evasion of Bactericidal Antibody by Haemophilus influenzae
por: Clark, Sarah E., et al.
Publicado: (2012)

Proteomics of Host-Helminth Interactions
por: Robinson, Mark W., et al.
Publicado: (2021)

Phosphorylcholine-based stealthy nanocapsules enabling tumor microenvironment-responsive doxorubicin release for tumor suppression
por: Liu, Gan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h3495f0pa2lhe7fd0695h0a9o8